Epstein Secrets

History Of Cutting Corners. The New York Times <https://www.nytimes.com/2020/07/27/science/coronavirus-retracted-studies-data.html> (7/27, Gabler, Rabin, 18.61 M) reports that Sapan Desai, along with a Harvard professor, "produced two studies in May that almost instantly disrupted multiple clinical t

vaccine before." USA Today <https://www.usatoday.corn/stoty/news/2020/07/27/large-scale-trials- possible-covid-19-vaccines-begin/5518981002/> (7/27, Weintraub, 10.31M), the Washington Times <https://www.washingtontimes.corn/news/2020/jul/27/virus-vaccine-put-to-final-test-in-thousands-of-vo/> (7/27, Neerg

Not Inmates, Receive Priority For Vaccine. The New York Times <https://www.nytimes.com/2020/11/30/health/coronavirus-vaccine-prisons.html> (11/30, Rabin, 18.61M) reports, "Federal officials have suggested that corrections staff receive high priority for a coronavirus vaccine, but not the millions of

" USA Today <https://www.usatoday.corn/story/news/health/2020/11/30/modema-emergency-fda-authorization- covid-19-vaccine-pfizer/6376336002/> (11/30, Weintraub, 10.31M) reports Modema's latest findings "showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placebo

ded that "there has been little evidence that schools have contributed meaningfully to increased community transmission." The New York Times (1/26, Rabin, 20.6M) reports, "On Tuesday, federal health officials weighed in with a call for returning children to the nation's classrooms as soon as possible,

in newly diagnosed, non-hospitalized COVID-19 patients at high risk of serious illness because of age or other health conditions." USA Today (1/26, Weintraub, 12.7M) reports Lilly's drug bamlanivimab was authorized by the FDA "late last year and has been used by 125,000 high-risk patients nationwide based

from home during his isolation." Federal Officials Suggest Corrections Staff, Not Inmates, Receive Priority For Vaccine. The New York Times (11/30, Rabin, 18.61M) reports, "Federal officials have suggested that corrections staff receive high priority for a coronavirus vaccine, but not the millions of

stage testing is complete," while the European Medicines Agency "has signaled it also is open to faster 'conditional' clearance." USA Today (11/30, Weintraub, 10.31M) reports Moderna's latest findings "showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placeb

ng initially infected. Colleagues Say Doctor Responsible For Discredited Studies Has History Of Cutting Corners. The New York Times (7/27, Gabler, Rabin, 18.61M) reports that Sapan Desai, along with a Harvard professor, "produced two studies in May that almost instantly disrupted multiple clinical t

fight the virus," and "while early studies show promise, mRNA technology has never been used to make a successful vaccine before." USA Today (7/27, Weintraub, 10.31M), the Washington Times (7/27, Neergaard, 492K), CQ Roll Call (7/27, Siddons, 154K) and New York Times (7/27, Grady, 18.61M), among other ne

ng initially infected. Colleagues Say Doctor Responsible For Discredited Studies Has History Of Cutting Corners. The New York Times (7/27, Gabler, Rabin, 18.61M) reports that Sapan Desai, along with a Harvard professor, "produced two studies in May that almost instantly disrupted multiple clinical t

fight the virus," and "while early studies show promise, mRNA technology has never been used to make a successful vaccine before." USA Today (7/27, Weintraub, 10.31M), the Washington Times (7/27, Neergaard, 492K), CQ Roll Call (7/27, Siddons, 154K) and New York Times (7/27, Grady, 18.61M), among other ne

from home during his isolation." Federal Officials Suggest Corrections Staff, Not Inmates, Receive Priority For Vaccine. The New York Times (11/30, Rabin, 18.61M) reports, "Federal officials have suggested that corrections staff receive high priority for a coronavirus vaccine, but not the millions of

stage testing is complete," while the European Medicines Agency "has signaled it also is open to faster `conditional' clearance." USA Today (11/30, Weintraub, 10.31M) reports Moderna's latest findings "showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placeb